Datavault AI Inc. (DVLT) Datavault operates as a data science technology firm, specializing in secure data management within the Web 3.0 environment. Its core expertise spans blockchain integration, artificial intelligence, and innovative approaches to data monetization. The company's unique, patented platform is designed to empower users with the ability to visualize, accurately value, and securely commercialize their data holdings. This robust system is utilized across a range of industries, including but not limited to marketing, real estate, and various government applications.
Sector: Services-Business Services, NEC
Industry: Software - Infrastructure
Datavault AI Inc. OTC:DVLT OTC (suspended from Nasdaq on Nov 17, 2026) Technology · Software - Infrastructure
Mkt Cap $28.3M
EV -
SI 17.7%
Net Cash/Sh -
CLOSED · Nov 17 +6.43%$0.0298 CLOSED · Nov 17 Prev close $0.0280 +6.43%Close $0.0298 0.00% AH close $0.0298 VOL 41.93M $ Vol $1.16M RVOL 0.52x
Mkt Cap $28.3M
EV -
VOL 41.93M sh
$ Vol $1.16M
RVOL 0.52×
SI 17.7%
Net Cash/Sh -
Press Release ● Major
Datavault AI Receives Notice of Nasdaq Trading Suspension; Common Stock Eligible to Trade on OTC Markets
Datavault AI announced that Nasdaq will suspend trading in its common stock effective November 17, 2026, after which shares are expected to trade on OTC Markets. The suspension stems from non-compliance with Nasdaq's $1.00 minimum bid price rule, and the low stock price rule triggered by a closing bid below $0.10 for ten consecutive business days.
• 4d ago AI analysis › Press Release ● Major
/C O R R E C T I O N - Nathaniel Bradley/
Datavault AI founder Nathaniel Bradley sued the company's board in Delaware Court of Chancery, asking the court to void his removal as CEO and restore him to office. The complaint alleges Chairman/CFO Brett Moyer suspended Bradley without a board vote and concealed a $90-$100 million financing offer from independent directors.
• 7d ago AI analysis › Press Release
Datavault AI and Biochar Now Combine Insured Carbon Removal Credits with Patented Tokenization Technology
Datavault AI announced a global strategic collaboration with Biochar Now to distribute verified, insured carbon removal credits using Datavault's patented tokenization technology (U.S. Patent No. 12,443,977). Biochar Now will pay Datavault for its technology and services, with Datavault handling demand generation, buyer development, and distribution; specific financial terms were not disclosed.
• 8d ago AI analysis › Press Release ● Critical
Datavault Board of Directors Appoints Brett Moyer as Chief Executive Officer and President; Names Kimberly Briskey Chair of the Board
Datavault AI's board removed Nathaniel Bradley as CEO and President on November 1, 2026, and appointed Brett Moyer as CEO and President, effective immediately. The board completed a full governance reset: Kimberly Briskey becomes Chair, Sri Peruvemba Vice Chair, Teri Gallo COO, Stanley Mbugua CFO, and Christopher R. Hardt chairs the Audit Committee. Bradley remains a director; former executive Sonia Choi is no longer with the company and is not authorized to act on its behalf.
• 11d ago AI analysis › Press Release
DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
DataMEDS AI (NASDAQ: MEDS) terminated the Second Amended and Restated letter of intent dated October 19, 2026 with Datavault AI (NASDAQ: DVLT) and four other parties covering in-license or acquisition of IP in exchange for DataMEDS common stock, citing market conditions. DVLT will no longer receive shares under the terminated LOI, and DataMEDS states it owes no fees or obligations as a result of the termination.
• 14d ago AI analysis › Press Release
Lifshitz Law PLLC Announces Investigations of Replimune Group, Inc. (NASDAQ: REPL), Datavault AI Inc. (NASDAQ: DVLT), Blaize Holdings, Inc. (NASDAQ: BZAI), and ARS Pharmaceuticals (NASDAQ: SPRY)
Lifshitz Law PLLC announced it is investigating possible securities-law violations at Blaize Holdings (BZAI), Replimune, Datavault AI, and ARS Pharmaceuticals. The allegations against Blaize center on claims that it announced transactions with entities unequipped to conduct meaningful business to create an appearance of growth and improperly recognized revenue.
• 21d ago AI analysis › Press Release
Datavault AI Expands WiSA Patent Portfolio with 13 U.S. Patent Milestones in 2026
Datavault AI recorded 13 U.S. patent milestones in 2026 for its WiSA wireless audio portfolio: three issued patents and 10 applications receiving Notices of Allowance from the USPTO. The patents cover wireless audio transport, synchronization, speaker localization, error concealment, multi-speaker processing, and device pairing, aimed at next-generation consumer electronics.
• 22d ago AI analysis › Press Release
Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
Datavault AI signed a non-binding LOI to acquire a 19.9% fully diluted equity stake in DataMEDS AI in exchange for expanding its existing technology license to include Datavault AI Health capabilities. Datavault AI retains ownership of its underlying IP, while DataMEDS assumes commercialization costs and Datavault AI expects to participate in potential royalty revenue — a capital-efficient licensing-plus-equity structure. The company would also gain the right to one DataMEDS board seat.
• 26d ago AI analysis › Press Release
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
Datavault AI is party to an amended and restated non-binding LOI under which DataMEDS AI (NASDAQ: MEDS) would expand its exclusive license of Datavault AI's healthcare-related intellectual property, with DVLT receiving equity participation in DataMEDS plus royalties on use of its technologies. The proposed transaction would also reunite the QOLPOM IP portfolio — biometric verification for drone and home drug delivery — from EOS Technology Holdings and Scilex, and have DataMEDS acquire a controlling interest in Tollo Health, targeting a Q4 2026 close.
• 26d ago AI analysis › Press Release
DataMeds Regains Compliance With NASDAQ Listing Standards
DataMeds AI (NASDAQ:MEDS) received a Nasdaq Compliance Notice dated October 19, 2026 confirming it has regained compliance with Listing Rule 5550(b)(1), the minimum stockholders' equity requirement of $2.5 million. The company had been in delisting proceedings since April 13, 2026 for failing both the $1.00 minimum bid-price and equity tests; bid-price compliance was restored June 9, 2026, and October 2026 Form 8-K filings confirmed stockholders' equity exceeded $2.5 million. Compliance is not fully durable: if the company fails to evidence compliance in its next periodic report, it may again face delisting.
• 28d ago AI analysis › Press Release
Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption
Datavault AI received a notice of allowance from the USPTO for its Data Futures Platform patent application (No. 17/441,847), covering systems for valuing data assets, tokenization, and blockchain-based transaction verification. The company tied the milestone to the SEC's September 17, 2026 temporary Innovation Exemption facilitating on-chain trading of certain tokenized NMS stocks, arguing its IP supports emerging tokenized-market infrastructure.
• 1mo ago AI analysis › Press Release
Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Board of Directors
Datavault AI appointed Jeffrey Tirman to its Board of Directors effective October 12, 2026, designated by NYIAX in connection with Datavault AI's recently completed acquisition of NYIAX. Tirman, through his family office Abri Capital Ltd., holds 26 million DVLT shares and brings over 35 years of international investment management and corporate restructuring experience.
• 1mo ago AI analysis › Press Release
Datavault AI to Debut Tort Token Capabilities at the Mass Torts Made Perfect Conference in Las Vegas
Datavault AI will attend the Mass Torts Made Perfect conference (October 13-15, 2026, Bellagio, Las Vegas), where CEO Nathaniel T. Bradley will present its tokenization capabilities for tort litigation. The presentation introduces potential capabilities in tokenizing tort litigation to mass tort practitioners and litigation funders; no contracts, revenues, or binding commitments were disclosed.
• 1mo ago AI analysis › Press Release
Datavault AI to Attend the 2026 Maxim Growth Summit
Datavault AI announced it will attend the 2026 Maxim Growth Summit, held October 12-14 at the Hard Rock Hotel NYC. Chairman and CFO Brett Moyer will hold one-on-one meetings with institutional investors and Maxim research analysts on October 13.
• 1mo ago AI analysis › Press Release
Datavault AI Appoints Christopher R. Hardt as Independent Director Following NYIAX Acquisition
Datavault AI appointed Christopher R. Hardt to its board as an independent director, effective October 3, 2026, designated by NYIAX under the August 2026 acquisition agreement. Hardt is a former PwC partner with over 30 years of experience in SEC reporting, M&A, and corporate governance, and previously served on NYIAX's board.
• 1mo ago AI analysis › Press Release
Datavault AI CEO to Present "Operating System for Tokenized Assets" at XRP Seoul 2026
Datavault AI CEO Nathaniel T. Bradley will present "Operating System for Tokenized Assets" at XRP Seoul 2026 on Oct. 3 in Seoul, arguing valuation, credentialing and verified metadata belong in one operating layer beneath tokenized real-world assets. The company will exhibit at the conference, deploy its ADIO acoustic data transmission technology from the keynote stage, and distribute the first XRP Seoul commemorative collectible token minted on the XRP Ledger to attendees.
• 1mo ago AI analysis › Press Release
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
DataMeds AI (NASDAQ:MEDS) announced that Interim Co-CEO Gerald Commissiong will present 'What Patients Really Want' at the 2026 National Telehealth and Virtual Care Summit in Las Vegas on September 28, 2026. The presentation will focus on patient ownership of health data and the company's 'Health Lives Here' campaign and mobile app launched with NFL Alumni Health.
• 1mo ago AI analysis › Press Release ● Major
Datavault AI Announces Rights Offering to Shareholders
Datavault AI's board approved a rights offering to all shareholders, with a record date of October 9, 2026 and Moody Capital Solutions acting as dealer manager. The structure includes up to $50 million of Common Units priced at $0.20 each (with staged Series A/B rights at $0.25 and $0.30 strikes) and up to $75 million of Preferred Units at $25.00 carrying a $2.10 annual cumulative dividend and senior ranking over common stock. Proceeds are earmarked for working capital and general corporate purposes, potentially including acquisitions and strategic transactions.
• 1mo ago AI analysis › 82 law-firm class-action alerts